Chemical Compound Review:
Rilmakalim 1-[(3S,4S)-3-hydroxy-2,2- dimethyl-6...
Synonyms:
rimalkalim, Rilmakalime, Rilmakalimum, HOE-234, CHEMBL275758, ...
- Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-beta-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies. Billman, G.E., Houle, M.S., Englert, H.C., Gögelein, H. J. Pharmacol. Exp. Ther. (2004)
- Mechanisms of L-NG nitroarginine/indomethacin-resistant relaxation in bovine and porcine coronary arteries. Graier, W.F., Holzmann, S., Hoebel, B.G., Kukovetz, W.R., Kostner, G.M. Br. J. Pharmacol. (1996)
- Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium. Wuest, M., Kaden, S., Hakenberg, O.W., Wirth, M.P., Ravens, U. Naunyn Schmiedebergs Arch. Pharmacol. (2005)
- KATP channel openers reverse immune complex-induced airways hyperreactivity independently of smooth muscle relaxation. Buchheit, K.H., Hofmann, A. Naunyn Schmiedebergs Arch. Pharmacol. (1996)
- Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098. Kääb, S., Zwermann, L., Barth, A., Hinterseer, M., Englert, H.C., Gögelein, H., Näbauer, M. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. (2003)
- Selective inhibition of pinacidil effects by estrogen in guinea pig heart. Kocić, I., Gruchała, M., Petrusewicz, J. International journal of cardiology. (2006)
- Ca2+-transients induced by K+ channel openers in isolated coronary capillaries. Langheinrich, U., Mederos y Schnitzler, M., Daut, J. Pflugers Arch. (1998)
- Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrate. Linz, W., Klaus, E., Albus, U., Becker, R., Mania, D., Englert, H.C., Schölkens, B.A. Arzneimittel-Forschung. (1992)
- Cellular mechanisms controlling EDRF/NO formation in endothelial cells. Busse, R., Lückhoff, A., Mülsch, A. Basic Res. Cardiol. (1991)
- Antiarrhythmic and electrophysiological effects of the novel KATP channel opener, rilmakalim, in rabbit cardiac cells. Riccioppo Neto, F., Mesquita Júnior, O., Olivera, G.B. Gen. Pharmacol. (1997)
- Hypotonic stress increases efficacy of rilmakalim, but not pinacidil, to activate ATP-sensitive K(+) current in guinea pig ventricular myocytes. Kocic, I., Hirano, Y., Hiraoka, M. J. Pharmacol. Sci. (2004)
- Differential antivasoconstrictor effects of levcromakalim and rilmakalim on the isolated human mammary artery and saphenous vein. Novaković, A., Gojković-Bukarica, L., Beleslin-Cokić, B., Japundzić-Zigon, N., Sajić, Z., Nezić, D., Perić, M., Djukanović, B., Kazić, T. J. Pharmacol. Sci. (2003)
- HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells. Gögelein, H., Hartung, J., Englert, H.C., Schölkens, B.A. J. Pharmacol. Exp. Ther. (1998)
- Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Krause, E., Englert, H., Gögelein, H. Pflugers Arch. (1995)